12:00 AM
 | 
Oct 26, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Colcrys colchicine regulatory update

FDA approved an NDA from URL for Colcrys colchicine to prevent gout flares. The low dose formulation of colchicine...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >